Source-linked appointments, departures, and role changes from SEC 8-K Item 5.02 filings. Every card cites the SEC source.
Showing 151–200 of 280
On April 7, 2026, the Board of Directors (the “Board”) of Prime Medicine, Inc. (the “Company”) appointed Svetlana Makhni as the Chief Financial Officer and the principal financial officer of the Company effective as of April 16, 2026.
On April 9, 2026, Starz Entertainment Corp., a corporation organized under the laws of the province of British Columbia, Canada (hereinafter the “Company”), announced that Audrey Lee, Executive Vice President and General Counsel, will be retiring effective May 1, 2026.
On April 10, 2026, Michael Niggli notified ESS Tech, Inc. (the “Company”) that he is resigning from the Company’s Board of Directors (the “Board”), Audit Committee and Nominating and Corporate Governance Committee, effective as of the date of the Company’s 2026 annual meeting of stockholders to be held on May 29, 2026.
Mr. McDonnell will continue his role as Chief Financial Officer with the Company through April 30, 2026, before transitioning to employment with the Company in a non-officer capacity
announced the appointment of Sean Woodward as the Company’s Executive Vice President and Chief Financial Officer, effective May 1, 2026.
the Board appointed Gregory M. Fischer to serve as a Class III director, effective immediately
On April 8, 2026, Solana Company (the “Company”) and Antonella Favit-Van Pelt, MD, PhD, mutually agreed that Dr. Favit-Van Pelt would separate from the Company and resign as the Company’s Chief Medical Officer, effective as of April 8, 2026
On April 10, 2026, Royale Energy, Inc. (OTC: ROYL) (the "Company") appointed Micheal McCaskey to its Board of Directors (the "Board), effective immediately.
On April 09, 2026, William Campbell submitted to the Company’s Board of Directors (the “Board”) notice of his resignation from his position as a director of the Company (including the Compensation, Corporate Governance, and Audit Committees of the Board), with such resignation to be effective immediately.
On April 8, 2026, Wabash National Corporation (the “Company”) announced that Michael N. Pettit will transition from his role as Senior Vice President, Chief Growth Officer effective on April 8, 2026 (the “Transition Date”).
Max Reinhardt, the Company’s President, Global Spine, will be departing as an executive and employee on or about June 12, 2026.
On April 9, 2026, Science Applications International Corporation (the “Company”) announced that Paul Eremenko and Admiral Michael Rogers, USN Retired, were appointed as a members of the Board of Directors of the Company (the “Board”) for an initial term beginning on April 8, 2026 (the “Effective Date”)
On April 9, 2026, Science Applications International Corporation (the “Company”) announced that Paul Eremenko and Admiral Michael Rogers, USN Retired, were appointed as a members of the Board of Directors of the Company (the “Board”) for an initial term beginning on April 8, 2026 (the “Effective Date”)
On April 7, 2026, Sudarsan Thattai, Chief Information Officer and Chief Transformation Officer of Lineage, Inc. (the “Company”), notified the Company that he plans to retire from the Company on April 2, 2027 (the “Retirement Date”).
On April 1, 2026, Michael L. Giorgio was appointed as the Chief Operating Officer of MVB Financial Corp. (the "Company") and its wholly-owned bank subsidiary, MVB Bank, Inc., in addition to his current Chief Information Officer position, effective April 1, 2026.
On April 3, 2026, Emily Rooney notified Byrna Technologies Inc. (the “Company”) of her decision not to stand for re-election to the Company’s Board of Directors
On April 6, 2026, Stephen P. MacMillan informed the Board of Directors of Hologic, Inc. (the “Company”) of his retirement as President and Chief Executive Officer and as Chairman of the Board of Directors of the Company, contingent upon, and effective as of immediately after, the closing of the acquisition of the Company by affiliates of funds managed by Blackstone Inc. and TPG Global, LLC pursuant to the Agreement and Plan of Merger, dated October 21, 2025, by and among the Company, Hopper Parent Inc. and Hopper Merger Sub Inc (the “Merger”).
On March 31, 2026, Kathleen F. Burke notified MKS Inc. (the “Corporation”) of her intent to retire as Executive Vice President, General Counsel and Secretary of the Corporation effective June 1, 2026.
On April 6, 2026, Gaurav Aggarwal, a director of Unicycive Therapeutics, Inc. (the “Company”), resigned from the Board of Directors of the Company.
On March 30, 2026, Stephen Ruffini, the Chief Financial Officer of Village Farms International, Inc. (the “Company”), notified the Company of his intent to transition away from the role of Chief Financial Officer as part of the Company’s succession planning process.
On March 30, 2026, Jeff Haywood resigned from the Board of Directors (the “Board”) of Definitive Healthcare Corp. (the “Company”) and as a member of the Human Capital Management and Compensation Committee (the “Compensation Committee”) of the Board, effective immediately.
On April 1, 2026, the remaining members of the Board of Directors of the Company appointed Joseph F. Rossetti to the Company’s Board of Directors, effective immediately, to fill the vacancy created by Mr. Hemmann’s resignation.
On March 31, 2026, J. Mark Hemmann notified ESG Inc. (the “Company”) of his resignation as a member of the Company’s Board of Directors, effective immediately.
On April 2, 2026, Booking Holdings Inc. (the "Company") announced that it has appointed Caroline Sullivan as its Senior Vice President, Chief Accounting Officer, and Controller effective as of April 29, 2026.
Additionally, the Board appointed Ms. Curtin to serve as a director to fill the vacancy created by Mr. Tiedemann’s departure.
On March 30, 2026, the Board appointed Nancy Curtin as the Company’s Interim Chief Executive Officer, effective March 30, 2026.
On March 30, 2026, AlTi Global, Inc. (the “Company”) announced that the Board of Directors of the Company (the “Board”) and Michael Tiedemann, Chief Executive Officer of the Company, agreed that Mr. Tiedemann will step down as the Company’s Chief Executive Officer, effective March 30, 2026.
Effective upon the closing of the Transaction, Robert Barnes, who served as President, ResCare Community Living, resigned from the Company.
on March 30, 2026, Mingxing Lin resigned from the Board, effective immediately.
On March 26, 2026, the Board elected Robert Hammond as an independent director of the Company.
On March 26, 2026, Tore Ivar Slettemoen resigned as a member of the board of directors (the “Board”) of the Company, effective immediately
In addition, effective March 27, 2026, Shannon Ghia resigned as a Director of the Sponsor and as President and Chief Executive Officer of the Sponsor.
Also on March 27, 2026, Mr. Jacobs was appointed as the President and Chief Executive Officer of the Sponsor.
On March 25, 2026, the Board of Directors of Cross Country Healthcare, Inc. (the “Company”) approved the appointment of Amiee Hawkins as Chief Operating Officer of the Company, effective as of March 28, 2026 (the “Appointment”).
In connection with Mr. Dubin’s appointment to the Board, he was appointed to serve on the Board’s Audit Committee, and the newly formed Finance Committee.
Pursuant to the Cooperation Agreement, in connection with Mr. Robson’s appointment to the Board, he was appointed to serve on the Board’s Nominating and Governance Committee, and the newly formed Finance Committee.
Additionally, on March 26, 2026, the Company’s Board of Directors appointed Bhisham (Ajay) Khare, the Company’s Chief Executive Officer and Principal Financial Officer and a Director of the Company, to serve as the Company’s Principal Accounting Officer (“PAO”), effective as of March 31, 2026.
On March 26, 2026, Unnikrishnan (Unni) Balakrishnan Nambiar resigned from his position as Chief Technology Officer of Aeries Technology, Inc. (the “Company”), effective March 31, 2026, to take a leadership position with the Company’s wholly-owned subsidiary in India, Aeries Technology Group Business Accelerators Private Limited.
Ryan Greenier, Executive Vice President and Chief Financial Officer, will serve as Interim Chief Accounting Officer.
On March 31, 2026, Thomas A. Dineen will step down from his role as Chief Financial Officer of Sturm, Ruger & Company, Inc. (the "Company").
On April 1, 2026, Andrew T. Wieland will succeed Mr. Dineen as Chief Financial Officer of the Company and will also become a Senior Vice President of the Company.
On March 23, 2026, Dr. Jonathan Goldman and Mitchell Chan, members of the board of directors (the “ Board ”) of Avalo Therapeutics, Inc. (the “ Company ”), each notified the Company of his decision to not stand for re-election to the Board at the Company’s 2026 Annual Meeting of Stockholders
On March 23, 2026, Dr. Jonathan Goldman and Mitchell Chan, members of the board of directors (the “ Board ”) of Avalo Therapeutics, Inc. (the “ Company ”), each notified the Company of his decision to not stand for re-election to the Board at the Company’s 2026 Annual Meeting of Stockholders
On March 24, 2026, Ardent Health, Inc. (the “Company”) and Ethan Chernin determined that Mr. Chernin would no longer serve as President, Hospital Services and would depart the Company effective that day.
Matthew M. Pullins, Executive Vice President – Chief Financial Officer and Treasurer of Farmer Mac will serve as interim principal accounting officer, effective April 8, 2026.
On March 24, 2026, Gregory N. Ramsey notified the Federal Agricultural Mortgage Corporation (“Farmer Mac”) of his decision to retire from his position as Vice President – Chief Accounting Officer (Farmer Mac’s principal accounting officer), effective April 8, 2026.
Vikram Bajaj and John Bibb were appointed as directors of the Company.
Vikram Bajaj and John Bibb were appointed as directors of the Company.
On March 25, 2026, the Boards of Directors of CF Bankshares Inc. (the “Company”) and CFBank, National Association, the Company’s wholly owned subsidiary bank (“CFBank”), appointed Bradley Ringwald as a director to fill the vacancies created on the Boards of Directors of the Company and CFBank resulting from the previously reported resignation of Sundeep Rana.
elected Jeffrey J. Evans on March 26, 2026 to fill the newly created vacancy as a director for the Company and the Bank.
Pilot corpus: a static 200-row sample of 8-K Item 5.02 filings; not a real-time live feed. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. See methodology.